GoHealth, Inc. — fact timeline

Conor Colpoys was appointed as director at GoHealth, Inc..

“Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .”

Neal Goldman was appointed as director at GoHealth, Inc..

“Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .”

Scott Avila was appointed as director at GoHealth, Inc..

“Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .”

Vijay Kotte was appointed as director at GoHealth, Inc..

“Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .”

GoHealth, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1, 5550(b)(2)).

“June 9, 2026, the Company received a written notice (the “Nasdaq Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq has determined to delist the Company’s Class A common stock (Nasdaq: GOCO) from Nasdaq. Pursuant to the Nasdaq Notice, Nasdaq’s determination was based on (i) the filing of the Chapter 11 Cases and associated public interest concerns raised thereby, (ii) concerns regarding the residual equity interest of existing listed securities holders and (iii”

Michael Hargis resigned as Chief Operating Officer at GoHealth, Inc..

“The Company and Michael Hargis, its Chief Operating Officer, agreed that Mr. Hargis will be leaving the Company to pursue other opportunities on June 5, 2026.”

GoHealth, Inc. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2026-06-07).

“On June 7, 2026 (the “Petition Date”), GoHealth, Inc. (the “Company”), GoHealth Holdings, LLC (“GoHealth Holdings”), and certain of their direct and indirect subsidiaries (collectively with the Company and GoHealth Holdings, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) under Chapter 11 of Title 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) to implement a prepackaged chapter 11 plan of reorganization (the “Plan”).”

GoHealth, Inc. faced acceleration on credit facility of The principal amount of, and accrued and unpaid interest on, the outstanding indebtedness under the Debt Agreements has with Blue Torch Finance, LLC at accrued and unpaid interest maturing immediately due and payable.

“The filing of the Chapter 11 Cases constitutes an event of default under each of the following material debt agreements (together, the “Debt Agreements”): • Superpriority Senior Secured Credit Agreement, dated as of August 6, 2025 (the “Superpriority Credit Agreement”), by and among Norvax, LLC, as borrower, Blizzard Midco, LLC, the lenders and issuing banks party thereto, and Blue Torch Finance, LLC, as administrative agent and collateral agent; and • Credit Agreement, dated as of September 13, 2019 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof), by and among Norvax, LLC, as borrower, Blizzard Midco, LLC, the lenders and issuing banks party thereto, and Blue Torch Finance, LLC, as administrative agent and collateral agent.”

GoHealth, Inc. reported financial results for the twelve months ended December 31, 2025.

“On March 31, 2026 , GoHealth, Inc. issued a press release announcing its financial results for the twelve months ended December 31, 2025.”

GoHealth, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

“March 18, 2026, GoHealth, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires listed companies on The Nasdaq Global Market to maintain a minimum market value of listed securities of $35 million (the “MVLS Requirement”). The Notice also indicates that the Company does not meet the alternative continued listing standards set forth in Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), which require listed”

GoHealth, Inc. incurred term loan of $115,000,000 with Blue Torch Finance, LLC at Term SOFR plus 5.50% or Alternate Base Rate plus 4.50% maturing August 5, 2029.

“the Borrower entered into a Superpriority Senior Secured Credit Agreement (the “Priming Credit Agreement”), with Holdings, the lenders party thereto, and Blue Torch Finance, LLC, as administrative agent and as collateral agent. The Priming Credit Agreement governs a senior secured super priority term loan facility in an aggregate principal amount of $115.0 million (the “Priming Facility”)”

Katherine O'Halloran changed role as Chief Accounting Officer at GoHealth, Inc..

“Ms. O’Halloran, the Company’s current Interim Chief Financial Officer, will continue her service to the Company as Chief Accounting Officer following Mr. Shanahan’s appointment as Chief Financial Officer.”

Brendan Shanahan was appointed as Chief Financial Officer at GoHealth, Inc..

“appointed Brendan Shanahan as the Company’s Chief Financial Officer, effective October 14, 2024”

Christopher C. Litchford resigned as Director at GoHealth, Inc..

“On July 8, 2024, Christopher C. Litchford, a member of the Board, informed the Company of his intent to resign from the Board effective July 8, 2024.”

Abhiraj R. Modi was appointed as Director at GoHealth, Inc..

“On July 9, 2024, the Board appointed Abhiraj R. Modi as a Class II director of the Board.”

Alan Wheatley was appointed as Director at GoHealth, Inc..

“On July 9, 2024, the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”) appointed Alan Wheatley as a Class II director of the Board, effective immediately.”

Alexander Timm was appointed as Lead Independent Director at GoHealth, Inc..

“Alexander Timm will replace Mr. Flanagan as lead independent director.”

Joseph G. Flanagan resigned as Director at GoHealth, Inc..

“Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.”

Katherine O'Halloran was appointed as Interim Chief Financial Officer at GoHealth, Inc..

“The Company further announced the appointment of Chief Accounting Officer, Katherine O’Halloran, age 53, as the Interim Chief Financial Officer on June 4, 2024 while the Company searches for a permanent replacement.”

Jason Schulz resigned as Chief Financial Officer at GoHealth, Inc..

“On June 4, 2024, GoHealth, Inc. (the “Company”) announced the resignation of Jason Schulz as Chief Financial Officer.”

GoHealth, Inc. reported the quarter ended March 31, 2024 results: revenue $185.6 million, net income net loss of $21.3 million.

“digital health company, today announced financial results for the three months ended March 31, 2024. First Quarter Highlights • First quarter 2024 net revenues of $185.6 million, a slight increase compared to $183.2 million in the prior year period. • First quarter 2024 Submissions of 216,148, a 2,503 increase compared to 213,645 Submissions in the prior”

GoHealth, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue $276.7 million, net income net loss was $2.3 million.

“Fourth quarter 2023 net revenues were $276.7 million, compared to $69.4 million in the prior year period. Full year 2023 net revenues were $734.7 million, compared to $631.7 million in 2022. • Fourth quarter 2023 net loss was $2.3 million and Adjusted EBITDA 1 was $57.0 million, improvements of 98.5% and 160.1%, respectively, compared to the prior year period. Full year 2023 net loss of $151.3 million and Adjusted EBITDA 1 of $75.1 million”

GoHealth, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue Fourth quarter 2023 net revenues were $276.7 million, compared to $69.4 million in the prior year period. Full year 2023, net income Fourth quarter 2023 net loss was $2.3 million ... Full year 2023 net loss of $151.3 million.

“GoHealth, Inc. issued a corrected press release announcing its financial results for the year ended December 31, 2023.”

GoHealth, Inc. reported the three months ended September 30, 2023 results: revenue $132.0 million, net income $56.2 million net loss.

“Third quarter 2023 net revenues of $132.0 million, compared to $133.1 million in the prior year period; YTD 2023 net revenues of $458.0 million, a decrease of $104.3 million compared to $562.3 million in the prior year period.”

GoHealth, Inc. reported Full Year 2023 results: revenue $800 - $850 million. Guidance raised.

“The Company updates its full year 2023 outlook and expects total net revenue 3 of $800 - $850 million and Adjusted EBITDA 1 of $120 - $140 million, both excluding non-Encompass BPO Services.”

GoHealth, Inc. reported the six months ended June 30, 2023 results: revenue $325.9 million, net income net loss of $92.8 million. Guidance raised.

“June 30, 2023. Second quarter 2023 net revenues of $142.8 million, a decrease of $15.9 million compared to $158.7 million in the prior year period. YTD 2023 net revenues of $325.9 million, a decrease of $103.3 million compared to $429.2 million in the prior year period. Second quarter 2023 Submissions of 162,837, a 5% improvement compared to 154,893 Submissions in”

GoHealth, Inc. reported the quarter ended June 30, 2023 results: revenue $142.8 million, net income net loss of $70.2 million. Guidance raised.

“marketplace and Medicare-focused digital health company, today announced financial results for the three and six months ended June 30, 2023. Second quarter 2023 net revenues of $142.8 million, a decrease of $15.9 million compared to $158.7 million in the prior year period. YTD 2023 net revenues of $325.9 million, a decrease of $103.3 million compared to $429.2 million”

Shane Cruz departed as Chief Strategy Officer at GoHealth, Inc..

“On June 6, 2023, GoHealth, Inc. (the “Company”) announced the departure of Shane Cruz, the current Chief Strategy Officer, whose employment will terminate as of June 30, 2023.”

GoHealth, Inc. shareholders approved Approval on an advisory basis, the compensation of the Company's named executive officers. at the 2023-05-23 meeting.

“Item 3 — Approval on an advisory basis, the compensation of the Company's named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 16,604,620 73,103 4,985 2,624,988”

GoHealth, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. at the 2023-05-23 meeting.

“Item 2 — Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 19,286,046 12,192 9,458 0”

GoHealth, Inc. shareholders approved Election of three Class III directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. at the 2023-05-23 meeting.

“Item 1 — Election of three Class III directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes Clinton P. Jones 16,476,370 206,338 2,624,988 Jeremy W. Gelber 16,482,346 200,362 2,624,988 Karolina H. Hilu 16,668,150 14,558 2,624,988”

GoHealth, Inc. reported for the three months ended March 31, 2023 results: revenue $183.2 million, net income net loss of $22.5 million. Guidance reaffirmed.

“million in the prior year period. First quarter 2023 net loss of $22.5 million compared to net loss of $37.2 million in the prior year period. First quarter 2023 net revenue of $183.2 million and Adjusted EBITDA 1 of $28.8 million compared to net revenue of $270.6 million and Adjusted EBITDA 1 of $11.1 million in the prior year period. First quarter 2023 Submissions”

GoHealth, Inc. amended Amendment No. 10 to the Credit Agreement with the lenders under the Credit Agreement valued at Converted the existing LIBOR-based rate applicable to the term loan and revolving credit facilities (effective 2023-03-15).

“Item 1.01 Entry into a Material Definitive Agreement On March 15, 2023, GoHealth, Inc. (the “Company”) entered into Amendment No. 10 to the Credit Agreement (“Amendment No. 10”). Amendment No. 10 amends the original credit agreement, dated as of September 13, 2019, as amended by Amendment No. 1 to the Credit Agreement and Incremental Facility Amendment, dated as of March 20, 2020, Incremental Facility Agreement and Technical Amendment No. 2 to the Credit Agreement, dated as of May 7, 2020, Incremental Facility Agreement No. 3, dated as June 11, 2020, Amendment No. 4 to the Credit Agreement and Incremental Facility Agreement, dated as of May 7, 2021, Amendment No. 5 to the Credit Agreement and Incremental Facility Agreement, dated as of June 11, 2021, Amendment No. 6 to the Credit Agreement and Incremental Facility Agreement, dated as of November 10, 2021, Amendment No. 7 to the Credit Agreement, dated as of March 14, 2022, Amendment No. 8 to the Credit Agreement, dated as of August 12,”

GoHealth, Inc. reported Full Year 2023 results: revenue $750 - $850 million. Guidance initiated.

“The Company provided its full year 2023 outlook, and expects total net revenue of $750 - $850 million and Adjusted EBITDA 1 of $100 - $140 million, both excluding non-Encompass BPO Services.”

GoHealth, Inc. reported Full year 2022 results: revenue $631.7 million, net income net loss of $376.4 million.

“Full year 2022 net revenue of $631.7 million, net loss of $376.4 million, and Adjusted EBITDA 1 of negative $129.8 million.”

GoHealth, Inc. reported fourth quarter 2022 results: revenue $69.4 million, net income net loss of $150.7 million.

“Fourth quarter 2022 net revenue of $69.4 million, net loss of $150.7 million, and Adjusted EBITDA 1 of negative $94.8 million.”

GoHealth, Inc. updated its the fourth quarter and year ended December 31, 2022 guidance (initiated).

“GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced unaudited financial results and select operating metrics for the fourth quarter and year ended December 31, 2022.”

GoHealth, Inc. reported financial results for the year ended December 31, 2022.

“On March 16, 2023 , GoHealth, Inc. issued a press release announcing its financial results for the year ended December 31, 2022.”

GoHealth, Inc. reported preliminary financial results for 2022.

“GoHealth, Inc. (Nasdaq: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced positive preliminary operating results achieved during the 2022 Annual Enrollment Period (AEP), for plans effective January 1, 2023, as a result of its Encompass-driven business transformation.”

Karolina Hilu was appointed as Class III Director at GoHealth, Inc..

“On January 5, 2023, the Board of Directors (the “Board”) of the Company appointed Karolina Hilu as a Class III director.”

GoHealth, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).

“November 22, 2022, the Company received a written letter (the “Extension Notice”) from Nasdaq notifying the Company that Nasdaq has granted the Company an additional 180 calendar days, or until May 22, 2023 (the “Extension Period”), to regain compliance with the Minimum Bid Price Requirement. In addition, on November 16, 2022, Nasdaq notified the Company that it had approved the Company’s application to transfer its listing from Nasdaq’s Global Market tier to the Capital Market tier, which was a prerequisite to obtaining the Extension Period. This transfer was effective at the opening of busin”

GoHealth, Inc.: Amended certificate of incorporation to effect a 1-for-15 reverse stock split, effective November 17, 2022 (effective 2022-11-17).

“Following such approval, the Company filed an amendment to its Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect the reverse stock split, with an effective time of 11:59 p.m. Eastern Time on November 17, 2022.”

GoHealth, Inc. reported Third quarter 2022 results: revenue net revenue of $133.1 million, net income net loss of $74.7 million.

“Third quarter 2022 net revenue of $133.1 million decreased 37% compared to the prior year period. YTD 2022 net revenue of $562.3 million decreased 8% compared to the prior year period. Third quarter 2022 net loss of $74.7 million compared to a net loss of $55.5 million in the prior year period.”

Christopher Litchford was appointed as Director at GoHealth, Inc..

“Mr. Litchford was appointed as a director by the Board of the Company on September 14, 2022”

Ms. Tawil resigned as Director at GoHealth, Inc..

“On September 11, 2022, Ms. Tawil resigned from the Board of the Company as a Centerbridge Director”

Shane Cruz was appointed as Chief Strategy Officer at GoHealth, Inc..

“Shane Cruz, who had been serving as Chief Operating Officer of GoHealth, Inc. (the “Company”), accepted a new position within the Company as Chief Strategy Officer.”

James A. Sharman resigned as President at GoHealth, Inc..

“James A. Sharman no longer serves as President of the Company.”

Brandon M. Cruz resigned as Non-Executive Co-Chair of the Board at GoHealth, Inc..

“Brandon M. Cruz, the Company’s Co-Founder, Chief Strategy Officer, Special Advisor to the Executive Team and Co-Chair of the Board of Directors, has resigned from his positions as Chief Strategy Officer and Special Advisor to the Executive Team. Mr. Cruz will continue to serve as Non-Executive Co-Chair of the Board”

Travis Matthiesen resigned as Chief Financial Officer at GoHealth, Inc..

“appointed Jason Schulz as the Company’s Chief Financial Officer, to succeed Travis Matthiesen as of the Effective Date.”

Jason Schulz was appointed as Chief Financial Officer at GoHealth, Inc..

“appointed Jason Schulz as the Company’s Chief Financial Officer, to succeed Travis Matthiesen as of the Effective Date.”